Campbell & Co Investment Adviser’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,023	Closed	-$188K	–	1167
2023 Q1	$188K	Buy	+10,023	New	+$165K	0.04%	740
2022 Q4	–	Sell	-11,167	Closed	-$214K	–	1043
2022 Q3	$214K	Sell	11,167 -2,878	-20%	-$52.4K	0.05%	602
2022 Q2	$214K	Sell	14,045 -3,705	-21%	-$54.8K	0.06%	584
2022 Q1	$362K	Sell	17,750 -2,850	-14%	-$58K	0.1%	400
2021 Q4	$601K	Buy	20,600 +6,500	+46%	+$186K	0.21%	145
2021 Q3	$304K	Sell	14,100 -7,900	-36%	-$191K	0.1%	367
2021 Q2	$564K	Buy	+22,000	New	+$470K	0.23%	122

Other funds holding CDMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Campbell & Co Investment Adviser's CDMO Position: Q2 2023 in Review

Campbell & Co Investment Adviser sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2023, closing a stake of 10,023 shares — an estimated $188K sold.

Campbell & Co Investment Adviser first reported a position in CDMO in Q2 2021 and held it in 7 quarters. The position peaked at $601K in Q4 2021. 169 funds tracked by Wall St. Rank hold CDMO as of Q2 2023.

Campbell & Co Investment Adviser reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Campbell & Co Investment Adviser sold 10,023 Avid Bioservices, Inc. Common Stock shares in Q2 2023, an estimated $188K.
Campbell & Co Investment Adviser first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
Campbell & Co Investment Adviser's Avid Bioservices, Inc. Common Stock position peaked at $601K in Q4 2021.
169 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2023.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2023, filed 11 Aug 2023.